E2F1 and liver cancer: CDCA5 was transcribed by E2F1 in hepatocytes, promotes tumorigenesis by enhancing cell proliferation and inhibiting apoptosis of hepatocellular carcinoma through the AKT pathway, and was significantly related to the poor prognosis of liver cancer patients.54, 55